4Steven HS,Elias C,Nancy LH,et al.WHO classification of tu-mours of haematopoietic and lymphoid tissues[M].4th ed.Lyon:International Agency for Research on Cancer,2008:200-202. 被引量：1
5Paiva B,Vidriales MB,Cerver6 J,et al.Multiparameter flow cy-tometric remission is the most relevant prognostic factor for mul-tiple myeloma patients who undergo autologous stem cell trans-plantation J].Blood,2008,112(10);4017-4023. 被引量：1
7Avet-Loiseau H.Role of genetics in prognostication in myeloma[J].Best Pract Res Clin Haematol,2007,20(4):625-635. 被引量：1
8Debes-Marun CS,Dewald GW,Bryant S,et al.Chromosome ab-normalities clustering and its implications for pathogenesis andprognosis in myeloma[J].Leukemia,2003,17(2):427-436. 被引量：1
9Ishikawa H,Tsuyama N,Kawano MM.Interleukin-6-induced pro-liferation of human myeloma cell associated with CD45 moloeu-les[J].Int J Hematol,2003,78(2):95-105. 被引量：1
10Bartl R5Frisch B.Clinical significance of bone marrow biopsyand plasma cell morphology in MM and MGUS[J].Pathol Biolol(Paris),1999,47(2):158-168. 被引量：1
